Andrew J. Forman

Partner
Washington,  DC  U.S.A.
Phone202-862-2243

Peer Rating
N/R
 N/R

Client Rating

Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials
 

Practice Areas

  • Antitrust
  • Antitrust Litigation & Civil Investigations
  • M&A Clearance & Counseling
  • Grand Jury and Cartel Investigations, Amnesty, and Compliance
  • Litigation
 
Contact InfoTelephone: 202-862-2243
Fax: 202 862 2400
http://www.cadwalader.com/professionals/andrew-forman
 
University Washington University, St. Louis, B.A., with honors, 1995
 
Law SchoolGeorgetown University Law Center, J.D., cum laude, 2000
 
Admitted2000, Maryland; 2002, District of Columbia
 
LanguagesFrench
 
Biography

Andrew Forman's practice involves counseling clients in a wide range of antitrust matters, with a specific focus on mergers and acquisitions, joint ventures, and representing clients in connection with investigations by the U.S. Department of Justice and the Federal Trade Commission (FTC). Andy also has experience in private antitrust litigation, including antitrust class action litigation. He has represented clients in matters involving a variety of industries, including the pharmaceutical, medical device, airline, automobile, software, semiconductor, industrial and engineered products, and consumer products industries. Among the clients Andy has represented are Eli Lilly, Salix, Anheuser-Busch InBev, US Airways, Pfizer, Microsoft, and Goodyear.

Recognized as a leading antitrust lawyer, Andy was recommended in The Legal 500 (2012 -2013) for his work in merger clearances and was part of the team accepting Benchmark Litigation's award for 2013 U.S. Antitrust Group of the Year and for a national Impact Case of the Year awardfor the US Airways/American merger clearance. His work for US Airways in connection with its merger with American Airlines was also recognized by Global Competition Review as the 2014 Matter of the Year. More recently, Andy's antitrust clearance work in connection with Eli Lilly & Company's acquisition of Novartis Animal Health was nominated for the Global Competition Review's 2015 Matter of the Year.

Prior to joining Cadwalader, Andy worked for the FTC's Bureau of Competition (Mergers I), where he helped lead antitrust investigations in large mergers and acquisitions in the pharmaceutical, medical device, consumer products, industrial products, and aircraft components industries.

Andy received his J.D., cum laude, from Georgetown University and his undergraduate degree as an Honors Graduate from Washington University in St. Louis. Following law school, he served as a judicial law clerk for the D.C. Court of Appeals. He is admitted to the bar in the District of Columbia and Maryland.

Clerkships
•Senior Judges' Chambers
District of Columbia Court of Appeals

Experience

Antitrust representations include:

•Salix Pharmaceuticals, Ltd. in connection with its approximately $14.5 billion total enterprise value acquisition by Valeant Pharmaceuticals International, Inc.
•Eli Lilly & Company in connection with its $5.4 billion acquisition of Novartis Animal Health.
•Acorda Therapeutics, Inc. in its pending acquisition of Civitas Therapeutics, Inc.
•Salix Pharmaceuticals in connection with its proposed transaction with Cosmo Technologies.
•US Airways in its $17 billion merger with American Airlines.
•Vertis Holdings, Inc., an advertising and direct mail company, in connection with its bankruptcy sale to rival Quad/Graphics, Inc.
•US Airways in its slot transaction with Delta Air Lines.
•Pfizer Inc. in its $68 billion acquisition of Wyeth Pharmaceuticals.
•Microsoft Corporation in numerous antitrust matters.
•Elan Corporation PLC in the $3.3 billion sale of its multiple sclerosis joint venture interest to Biogen Idec, Inc.
•Anheuser-Busch InBev in various antitrust matters.
•Goodyear Tire & Rubber Company in various antitrust matters.

News & Resources

NEWS

News Releases

Cadwalader Represents Salix Pharmaceuticals in Its Pending Acquisition by Valeant Pharmaceuticals Feb 22, 2015

Recent Press

New Deals - Lawyers on Major Transactions Jan 29, 2009

Recognition

Cadwalader's Antitrust Group Nominated for Pair of 2015 Global Competition Review Awards Feb 20, 2015

RESOURCES

Clients & Friends Memos

Takeaways from the Ninth Circuit's Opinion Affirming the FTC's Victory Against the St. Luke's/Saltzer Merger Feb 12, 2015

Events

So The Agency Wants to Talk: Advice and Issues in Pre-Complaint Depositions Mar 16, 2015

 
ISLN916984357
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

Takeaways from the Ninth Circuit’s Opinion Affirming the FTC’s Victory Against the St. Luke's/Saltzer Merger
Andrew J. Forman,Daniel J. Howley,Jonathan S. Kanter,Charles F. (Rick) Rule,Eric Sega, March 26, 2015
On February 10, 2015, the United States Court of Appeals for the Ninth Circuit affirmed a district court’s ruling that St. Luke’s Health System’s acquisition of the independent physician group Saltzer Medical Group violated the antitrust laws. This appellate victory is another in...
Profile Visibility
#3,263 in weekly profile views out of 57,949 lawyers in Washington, District of Columbia
#105,816 in weekly profile views out of 1,675,662 total lawyers Overall

Office Information

Andrew J. Forman

700 Sixth Street, N.W.
WashingtonDC 20001




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now